Nano-X Imaging (NASDAQ:NNOX - Get Free Report) posted its earnings results on Thursday. The company reported ($0.21) earnings per share for the quarter, topping analysts' consensus estimates of ($0.23) by $0.02, Zacks reports. Nano-X Imaging had a negative net margin of 465.38% and a negative return on equity of 27.63%. The company had revenue of $3.00 million for the quarter, compared to analyst estimates of $3.98 million.
Nano-X Imaging Stock Up 1.0%
NNOX traded up $0.05 during trading on Tuesday, hitting $5.18. 1,315,133 shares of the company traded hands, compared to its average volume of 1,738,478. Nano-X Imaging has a one year low of $3.75 and a one year high of $11.00. The stock's fifty day moving average is $5.09 and its 200 day moving average is $6.33. The firm has a market cap of $299.30 million, a P/E ratio of -6.09 and a beta of 2.03.
Institutional Investors Weigh In On Nano-X Imaging
A hedge fund recently raised its stake in Nano-X Imaging stock. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Nano-X Imaging Ltd. (NASDAQ:NNOX - Free Report) by 232.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,160,806 shares of the company's stock after purchasing an additional 1,510,806 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned 3.74% of Nano-X Imaging worth $10,793,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 21.49% of the company's stock.
Analyst Upgrades and Downgrades
A number of research firms have recently weighed in on NNOX. D. Boral Capital dropped their target price on Nano-X Imaging from $15.00 to $10.00 and set a "buy" rating on the stock in a report on Friday. Alliance Global Partners restated a "buy" rating on shares of Nano-X Imaging in a research note on Thursday. Finally, Cantor Fitzgerald cut their price objective on shares of Nano-X Imaging from $12.00 to $9.00 and set an "overweight" rating on the stock in a report on Tuesday, April 1st.
View Our Latest Stock Analysis on NNOX
Nano-X Imaging Company Profile
(
Get Free Report)
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.
Featured Articles
Before you consider Nano-X Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nano-X Imaging wasn't on the list.
While Nano-X Imaging currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
